Literature DB >> 33552606

Conjunctival Tarsal Actinic Keratosis Treated with Interferon Alfa-2b: A Rare Case Report and Literature Review.

Mónica Gimeno-Carrero1, María-Jesús Suárez-Fernández1, Beatriz Alonso-Martín1, Almudena de-Pablo-Cabrera1, María-Concepción Garrido-Ruíz2, Enrique Mencía-Gutiérrez1.   

Abstract

Conjunctival neoplasia is one of the most frequent tumors in the eye. Actinic keratosis (AK) or solar keratosis is a precancerous lesion that is included with other epithelial tumors. This alteration does not break the basal membrane. There is enough evidence of successful outcomes to consider interferon alfa-2b (IFN alfa-2b) as the first choice of treatment for this type of tumors. In addition, side effects are mild and uncommon. We report a case in an 83-year-old woman who was referred to evaluate a leukoplakia in the tarsal conjunctiva of the lower left eyelid that measured 1 cm in diameter. Pathological study revealed AK. After the INF alfa-2b treatment, we observed conjunctival hyperemia, noninfiltrated upper nasal de-epithelization, and inferior nasal bulla. AK with presentation in conjunctiva is rarely described and in tarsal conjunctiva is exceptional. It is the first case published with only tarsal conjunctiva affectation.
Copyright © 2021 Mónica Gimeno-Carrero et al.

Entities:  

Year:  2021        PMID: 33552606      PMCID: PMC7847316          DOI: 10.1155/2021/6616021

Source DB:  PubMed          Journal:  Case Rep Ophthalmol Med


  11 in total

Review 1.  The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.

Authors:  Jamshaid Anwar; David A Wrone; Arash Kimyai-Asadi; Murad Alam
Journal:  Clin Dermatol       Date:  2004 May-Jun       Impact factor: 3.541

Review 2.  Actinic keratosis.

Authors:  Riccardo Rossi; Moira Mori; Torello Lotti
Journal:  Int J Dermatol       Date:  2007-09       Impact factor: 2.736

3.  Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.

Authors:  Barry A Schechter; Amilia Schrier; Robert S Nagler; Edward F Smith; Gabriel E Velasquez
Journal:  Cornea       Date:  2002-01       Impact factor: 2.651

4.  Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.

Authors:  Afshan A Nanji; Christina S Moon; Anat Galor; Julia Sein; Patrick Oellers; Carol L Karp
Journal:  Ophthalmology       Date:  2014-01-09       Impact factor: 12.079

5.  Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.

Authors:  Megan A Rowlands; Joseph N Giacometti; Javier Servat; Miguel A Materin; Flora Levin
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 Jan/Feb       Impact factor: 1.746

Review 6.  The epidemiology of skin cancer.

Authors:  Thomas L Diepgen; V Mahler
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

7.  Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.

Authors:  Carol L Shields; Swathi Kaliki; H Jane Kim; Saad Al-Dahmash; Sanket U Shah; Sara E Lally; Jerry A Shields
Journal:  Cornea       Date:  2013-03       Impact factor: 2.651

8.  Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.

Authors:  Barry A Schechter; Aaleya F Koreishi; Carol L Karp; William Feuer
Journal:  Ophthalmology       Date:  2008-01-09       Impact factor: 12.079

9.  Coincidence of Inflamed Conjunctival Carcinoma in situ and Primary Pterygium.

Authors:  Hiroaki Endo; Satoru Kase; Yasuo Suzuki; Manabu Kase
Journal:  Case Rep Ophthalmol       Date:  2016-10-11

10.  A Rare Presentation of Actinic Keratosis Affecting the Tarsal Conjunctiva and Review of the Literature.

Authors:  Selina Khan; Melanie Chak
Journal:  Case Rep Ophthalmol Med       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.